Verschoor, Chris P.
Belsky, Daniel W.
Andrew, Melissa K.
Haynes, Laura
Loeb, Mark
Pawelec, Graham
McElhaney, Janet E.
Kuchel, George A.
Funding for this research was provided by:
Lung Health Foundation
National Institutes of Health,United States (R01 AG048023, R01 AG048023)
Article History
Received: 30 May 2022
Accepted: 17 August 2022
First Online: 23 August 2022
Declarations
:
: The study protocol was approved by the Institutional Review Board of the University of Connecticut Health Centre (UCHC) and the Health Sciences North Research Ethics Board and all study participants provided written informed consent to participate in the study.
: Not applicable.
: MAK reports payments for advisory activities from Sanofi, Pfizer and Seqirus (unrelated to the current study).